Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3

导出原文传递

翻译打印收藏纠错

作者： Kemeny, Lajos ^[1] ; Berggren, Lovisa ^[2] ; Dossenbach, Martin ^[3] ; Dutronc, Yves ^[4] ; Paul, Carle

作者单位： Univ Szeged, MTA SZTE Dermatol Res Grp, Szeged, Hungary ^[1] Paul Sabatier Univ, Dept Dermatol, Toulouse, France ^[2] Lilly Deutschland GmbH, Bad Homburg, Germany ^[3] Eli Lilly & Co, Indianapolis, IN 46285 USA ^[4]

关键词 Ixekizumab psoriasis severity Psoriasis Area and Severity Index

发布时间 2020-06-03

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of dermatological treatment

2019年30卷1/8期

19-26页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3

The Journal of dermatological treatment

相似文献

The Journal of dermatological treatment

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and safety of ixekizumab in patients with plaque psoriasis across different degrees of disease severity: results from UNCOVER-2 and UNCOVER-3

The Journal of dermatological treatment

相似文献

The Journal of dermatological treatment

相关期刊

检索历史清除